Invention Grant
- Patent Title: CYBP as a marker for lung cancer
- Patent Title (中): CYBP作为肺癌的标志物
-
Application No.: US13270482Application Date: 2011-10-11
-
Publication No.: US08951738B2Publication Date: 2015-02-10
- Inventor: Herbert Andres , Johann Karl , Julia Riedlinger , Markus Roessler , Michael Tacke , Michael Thierolf
- Applicant: Herbert Andres , Johann Karl , Julia Riedlinger , Markus Roessler , Michael Tacke , Michael Thierolf
- Applicant Address: US IN Indianapolis
- Assignee: Roche Diagnostics Operations, Inc.
- Current Assignee: Roche Diagnostics Operations, Inc.
- Current Assignee Address: US IN Indianapolis
- Agent Denise M. Everett
- Priority: EP09006609 20090515
- Main IPC: G01N33/53
- IPC: G01N33/53 ; G01N33/574
Abstract:
The present invention relates to the assessment of lung cancer. It discloses the use of protein CYBP in the assessment of lung cancer. It also relates to a method for assessing lung cancer in vitro using a liquid sample, derived from an individual by measuring CYBP in said sample. Measurement of CYBP can, e.g., be used in the early detection or in the follow-up of patients with lung cancer.
Public/Granted literature
- US20120196303A1 CYBP AS A MARKER FOR LUNG CANCER Public/Granted day:2012-08-02
Information query
IPC分类:
